These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15782130)

  • 1. BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase.
    Feki A; Jefford CE; Berardi P; Wu JY; Cartier L; Krause KH; Irminger-Finger I
    Oncogene; 2005 May; 24(23):3726-36. PubMed ID: 15782130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
    Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.
    Irminger-Finger I; Leung WC; Li J; Dubois-Dauphin M; Harb J; Feki A; Jefford CE; Soriano JV; Jaconi M; Montesano R; Krause KH
    Mol Cell; 2001 Dec; 8(6):1255-66. PubMed ID: 11779501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
    Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.
    Sauer MK; Andrulis IL
    J Med Genet; 2005 Aug; 42(8):633-8. PubMed ID: 16061562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ser46 phosphorylation of p53 is not always sufficient to induce apoptosis: multiple mechanisms of regulation of p53-dependent apoptosis.
    Kurihara A; Nagoshi H; Yabuki M; Okuyama R; Obinata M; Ikawa S
    Genes Cells; 2007 Jul; 12(7):853-61. PubMed ID: 17584297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
    Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
    Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
    Brodie KM; Henderson BR
    Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
    Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
    Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells.
    Araki R; Fukumura R; Fujimori A; Taya Y; Shiloh Y; Kurimasa A; Burma S; Li GC; Chen DJ; Sato K; Hoki Y; Tatsumi K; Abe M
    Cancer Res; 1999 Aug; 59(15):3543-6. PubMed ID: 10446957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
    Ryser S; Dizin E; Jefford CE; Delaval B; Gagos S; Christodoulidou A; Krause KH; Birnbaum D; Irminger-Finger I
    Cancer Res; 2009 Feb; 69(3):1125-34. PubMed ID: 19176389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 DNA-binding activity is stimulated by BARD1.
    Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
    Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [p53 activation by PI-3K family kinases after DNA double-strand breaks].
    Pernin D; Uhrhammer N; Verrelle P; Bignon YJ; Bay JO
    Bull Cancer; 2000 Sep; 87(9):635-41. PubMed ID: 11038413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: involvement of ATM pathway.
    Suzuki K; Inageda K; Nishitai G; Matsuoka M
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):83-91. PubMed ID: 17292432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation.
    Kapoor M; Hamm R; Yan W; Taya Y; Lozano G
    Oncogene; 2000 Jan; 19(3):358-64. PubMed ID: 10656682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase inhibitor 2-aminopurine overrides multiple genotoxic stress-induced cellular pathways to promote cell survival.
    Huang S; Qu LK; Cuddihy AR; Ragheb R; Taya Y; Koromilas AE
    Oncogene; 2003 Jun; 22(24):3721-33. PubMed ID: 12802279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.